{"id":"https://openalex.org/W54593518","doi":null,"title":"Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.","display_name":"Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W54593518","mag":"54593518","pmid":"https://pubmed.ncbi.nlm.nih.gov/23353839"},"language":"en","primary_location":{"id":"pmid:23353839","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23353839","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro endocrinology letters","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008388003","display_name":"Tom\u00e1\u0161 Groh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Tomas Groh","raw_affiliation_strings":["Department of Biochemistry, Charles University, Prague, Czech Republic. stiborov@natur.cuni.cz"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Charles University, Prague, Czech Republic. stiborov@natur.cuni.cz","institution_ids":["https://openalex.org/I21250087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019351423","display_name":"Jan Hrab\u011bta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Hrabeta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077879348","display_name":"Jitka Poljakov\u00e1","orcid":"https://orcid.org/0000-0003-4268-903X","observed_orcids":["https://orcid.org/0000-0003-4268-903X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jitka Poljakova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013532796","display_name":"Tom\u00e1\u0161 Eckschlager","orcid":"https://orcid.org/0000-0002-7813-1049","observed_orcids":["https://orcid.org/0000-0002-7813-1049"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomas Eckschlager","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5009212415","display_name":"Marie Stiborov\u00e1","orcid":"https://orcid.org/0000-0001-5430-4403","observed_orcids":["https://orcid.org/0000-0001-5430-4403"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie Stiborova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.42,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.53831947,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"33 Suppl 3","issue":null,"first_page":"16","last_page":"24"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.5327000021934509,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.5327000021934509,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.4016000032424927,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.01899999938905239,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9210000038146973},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.984000027179718},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7950000166893005},{"id":"https://openalex.org/keywords/drug-sequence","display_name":"drug sequence","score":0.5989999771118164},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.8270000219345093},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cell-cycle-distribution","display_name":"cell cycle distribution","score":0.843999981880188},{"id":"https://openalex.org/keywords/hypoxia","display_name":"hypoxia","score":0.9449999928474426},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibition","display_name":"topoisomerase II inhibition","score":0.8550000190734863},{"id":"https://openalex.org/keywords/drug-sensitization","display_name":"drug sensitization","score":0.6869999766349792},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.5849999785423279},{"id":"https://openalex.org/keywords/cell-growth-inhibition","display_name":"cell growth inhibition","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.9113548398017883},{"id":"https://openalex.org/C2775934118","wikidata":"https://www.wikidata.org/wiki/Q424169","display_name":"Propidium iodide","level":4,"score":0.7670083045959473},{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.6146422624588013},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.5943613648414612},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.5933845043182373},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5673938393592834},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5030845999717712},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.49720361828804016},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48704245686531067},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.46092885732650757},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4275391101837158},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.41397517919540405},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4094020128250122},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3671470880508423},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.3278084397315979},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24990105628967285},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1361592411994934},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.1252739131450653},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.11213284730911255},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06542322039604187},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.05419278144836426},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019046","descriptor_name":"Bone Marrow Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019046","descriptor_name":"Bone Marrow Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D019046","descriptor_name":"Bone Marrow Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23353839","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23353839","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro endocrinology letters","raw_type":"Journal Article"},{"id":"mag:54593518","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23353839","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W10911041","https://openalex.org/W98801929","https://openalex.org/W126188432","https://openalex.org/W170867664","https://openalex.org/W1818313483","https://openalex.org/W1947884488","https://openalex.org/W1963847519","https://openalex.org/W1965147058","https://openalex.org/W1965162210","https://openalex.org/W1969315337","https://openalex.org/W1976463957","https://openalex.org/W1977122455","https://openalex.org/W2006798419","https://openalex.org/W2015620660","https://openalex.org/W2020236755","https://openalex.org/W2021208131","https://openalex.org/W2028323816","https://openalex.org/W2031291993","https://openalex.org/W2033232071","https://openalex.org/W2034171802","https://openalex.org/W2034607919","https://openalex.org/W2035501441","https://openalex.org/W2056138506","https://openalex.org/W2058648267","https://openalex.org/W2067606868","https://openalex.org/W2069161814","https://openalex.org/W2077301074","https://openalex.org/W2080550678","https://openalex.org/W2080934311","https://openalex.org/W2088961696","https://openalex.org/W2090407227","https://openalex.org/W2100623352","https://openalex.org/W2102577783","https://openalex.org/W2110084716","https://openalex.org/W2131089732","https://openalex.org/W2133141633","https://openalex.org/W2144155453","https://openalex.org/W2147759897","https://openalex.org/W2160401113","https://openalex.org/W2160723017","https://openalex.org/W2161688817","https://openalex.org/W2167759122"],"related_works":["https://openalex.org/W2966571044","https://openalex.org/W1651388490","https://openalex.org/W2781577030","https://openalex.org/W1799791675","https://openalex.org/W7135437451","https://openalex.org/W2164311213","https://openalex.org/W2246142081","https://openalex.org/W170867664","https://openalex.org/W1993208712","https://openalex.org/W7135925400"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Etoposide":[1,288],"(Vepesid,":[2],"VP-16),":[3],"an":[4,125],"inhibitor":[5],"of":[6,17,20,51,78,100,116,135,157,179,183,194,196,206,212,214,222,241,261,325,327,345,348,362,369],"topoisomerase":[7,26],"II,":[8],"is":[9],"a":[10,60,69,105,203,209],"chemotherapeutic":[11],"drug":[12,34,54],"commonly":[13],"used":[14,306],"for":[15],"treatment":[16,264,347,368],"different":[18],"types":[19],"malignant":[21],"diseases.":[22],"By":[23],"inhibiting":[24],"the":[25,49,88,92,117,140,158,177,192,197,200,220,223,237,242,270,282,319,328,334,360,367],"II":[27],"enzyme":[28],"activity":[29],"in":[30,57,185,256,359],"cancer":[31],"cells,":[32],"this":[33,45,52],"leads":[35],"to":[36,41,104,168,171,301,321,366],"DNA":[37],"damage":[38],"and":[39,56,80,90,102,128,137,170,279,289,356],"subsequently":[40],"cell":[42,73,108,141,216,271,283],"death.":[43],"In":[44,235],"study,":[46],"we":[47],"investigated":[48],"effect":[50,134,260],"anticancer":[53],"alone":[55],"combination":[58,239],"with":[59,112,199,208,225,233,244,249,330,351,353],"histone":[61],"deacetylase":[62],"(HDAC)":[63],"inhibitor,":[64],"valproic":[65],"acid":[66],"(VPA),":[67],"on":[68,82,139,181,191],"human":[70,302],"UKF-NB-4":[71,83,106,162,303],"neuroblastoma":[72,107,163,215,304,349],"line.":[74],"METHODS:":[75],"The":[76,98,133,155,259,338],"effects":[77],"etoposide":[79,101,136,169,184,257,278,335,352],"VPA":[81,103,138,180,245,280,290,316,331],"cells":[84,118,164,188,198,224,243,305,320,329,350],"were":[85,291],"tested":[86],"under":[87],"normoxic":[89],"also":[91,174],"hypoxic":[93],"(1%":[94],"O2)":[95],"cultivation":[96,195,232,326],"conditions.":[97],"cytotoxicity":[99,182],"line":[109],"was":[110,119,144,218,228],"evaluated":[111],"MTT":[113],"assay.":[114],"Apoptosis":[115],"analyzed":[120],"by":[121,146,230,268],"flow":[122,147],"cytometry":[123],"using":[124,150],"Annexin":[126],"V":[127],"propidium":[129,151],"iodide":[130,152],"binding":[131],"method.":[132],"cycle":[142,272,284,294],"distribution":[143],"determined":[145],"cytometric":[148],"analysis":[149],"staining.":[153],"RESULTS:":[154],"results":[156,339],"study":[159],"demonstrate":[160],"that":[161,176,276,298],"are":[165,299],"sensitive":[166],"both":[167,277,312],"VPA.":[172,234],"They":[173],"indicate":[175],"impact":[178],"these":[186],"tumor":[187],"varies":[189],"depending":[190],"sequence":[193,205,324],"drugs.":[201],"As":[202],"suitable":[204],"cultivation,":[207],"high":[210,370],"rate":[211],"suppression":[213],"growth":[217],"found":[219,292,340],"preincubation":[221],"etoposide,":[226,322],"which":[227,274],"followed":[229],"their":[231,247],"contrast,":[236],"reversed":[238],"(preincubation":[240],"before":[246],"treating":[248],"etoposide)":[250],"did":[251],"not":[252],"give":[253],"any":[254],"increase":[255],"cytotoxicity.":[258],"such":[262],"combined":[263,346],"can":[265,332],"be":[266],"explained":[267],"measuring":[269],"distribution,":[273],"shows":[275],"change":[281],"phase":[285,295],"distribution.":[286],"CONCLUSION:":[287],"as":[293,308],"specific":[296],"drugs":[297,310],"cytotoxic":[300,336],"either":[307],"single":[309],"or":[311],"together.":[313],"However,":[314],"whereas":[315],"might":[317],"sensitize":[318],"inappropriate":[323],"decrease":[333],"efficacy.":[337],"here":[341],"warrant":[342],"further":[343],"studies":[344],"HDAC":[354],"inhibitors":[355],"may":[357],"help":[358],"design":[361],"new":[363],"protocols":[364],"geared":[365],"risk":[371],"neuroblastomas.":[372]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}